Will A US FDA Advisory Committee Be In Intercept's Future?

 
• By Derrick Gingery
Liver infection
Several factors point toward the FDA making the product one of the minority of applications receiving an advisory committee meeting in 2019. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers